MAPT and Alzheimer disease: Currently, the question remains whether AI-driven classification of data-rich HS images could provide retinal-indices that 1) relate to tau-PET status or to a combination of Aβ-PET and tau-PET status, and 2) remain specific to AD in cases with a simultaneous eye disease affecting the retina.